Cargando…

Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine

The feline immunodeficiency virus (FIV) vaccine called Fel-O-Vax(®) FIV is the first commercial FIV vaccine released worldwide for the use in domestic cats against global FIV subtypes (A–E). This vaccine consists of inactivated dual-subtype (A plus D) FIV-infected cells, whereas its prototype vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahay, Bikash, Yamamoto, Janet K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977270/ https://www.ncbi.nlm.nih.gov/pubmed/29789450 http://dx.doi.org/10.3390/v10050277

Ejemplares similares

FIV vaccine development and its importance to veterinary and human medicine: a review: FIV vaccine 2002 update and review
por: Uhl, E.W, et al.
Publicado: (2002)

Conserved HIV Epitopes for an Effective HIV Vaccine
por: Sahay, Bikash, et al.
Publicado: (2017)

Evaluation of a Point-of-Care Feline Immunodeficiency Virus (FIV) Test Kit (RapidSTATUS™ FIV) to Determine the FIV Status of FIV-Vaccinated and FIV-Unvaccinated Pet Cats in Australia
por: Cheang, Ashley, et al.
Publicado: (2022)

FIV as a Model for AIDS Vaccine Studies
por: Dunham, Stephen, et al.
Publicado: (2006)

Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

FIV as a Model for HIV: An Overview
por: Sparger, Ellen E.
Publicado: (2006)

Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax(®) FIV)
por: Westman, Mark, et al.
Publicado: (2021)

Applications of the FIV Model to Study HIV Pathogenesis
por: Miller, Craig, et al.
Publicado: (2018)

Feline T-cell lymphotropic lentivirus proteins; cat FIV virus used for the specific detection of FIV antibodies, production of antibodies and in vaccine; DNA sequence
Publicado: (1991)

FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge
por: Miller, Craig, et al.
Publicado: (2018)

Pathogenesis of oral FIV infection
por: Miller, Craig, et al.
Publicado: (2017)

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection
por: Hofmann-Lehmann, R., et al.
Publicado: (1995)

Lessons learned from human HIV vaccine trials
por: Pollara, Justin, et al.
Publicado: (2017)

Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors
por: Zhang, Zeli, et al.
Publicado: (2016)

Acute phase response to Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats
por: Korman, R.M., et al.
Publicado: (2012)

FIV cross-species transmission: An evolutionary prospective
por: Troyer, Jennifer L., et al.
Publicado: (2008)

The Molecular Biology of Feline Immunodeficiency Virus (FIV)
por: Kenyon, Julia C., et al.
Publicado: (2011)

Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV)
por: Mohammadi, Hakimeh, et al.
Publicado: (2012)

Colonic Immune Stimulation by Targeted Oral Vaccine
por: Kathania, Mahesh, et al.
Publicado: (2013)

Vaccine development lessons between HIV and COVID-19
por: Vasan, Sandhya, et al.
Publicado: (2021)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

Cancer vaccine: learning lessons from immune checkpoint inhibitors
por: Ye, ZhenLong, et al.
Publicado: (2018)

Feline Immunodeficiency Virus (FIV) Neutralization: A Review
por: Hosie, Margaret J., et al.
Publicado: (2011)

Construction and Testing of orfA +/- FIV Reporter Viruses
por: Fadel, Hind J., et al.
Publicado: (2012)

A Detailed Phylogenetic Analysis of FIV in the United States
por: Weaver, Eric A.
Publicado: (2010)

Cutaneous lesions associated with feline coronavirus, FIP, and FIV
Publicado: (2006)

Immunomodulator expression in trophoblasts from the feline immunodeficiency virus (FIV)-infected cat
por: Scott, Veronica L, et al.
Publicado: (2011)

Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3
por: Heaslet, Holly, et al.
Publicado: (2007)

Lessons in AIDS Vaccine Development Learned from Studies of Equine Infectious, Anemia Virus Infection and Immunity
por: Craigo, Jodi K., et al.
Publicado: (2013)

The Potential Contribution of Caveolin 1 to HIV Latent Infection
por: Sahay, Bikash, et al.
Publicado: (2020)

DNA Immunization for HIV Vaccine Development
por: Chen, Yuxin, et al.
Publicado: (2014)

The virus–receptor interaction in the replication of feline immunodeficiency virus (FIV)()
por: Willett, Brian J, et al.
Publicado: (2013)

Enrichment Preferences of FIV-Infected and Uninfected Laboratory-Housed Cats
por: Kennedy, Claudia J., et al.
Publicado: (2018)

Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
por: Zhang, Zeli, et al.
Publicado: (2018)

Influence of the FIV Status and Chronic Gingivitis on Feline Oral Microbiota
por: Older, Caitlin E., et al.
Publicado: (2020)

Virus–host interaction in feline immunodeficiency virus (FIV) infection
por: Taniwaki, Sueli Akemi, et al.
Publicado: (2013)

BLV: lessons on vaccine development
por: Abdala, Alejandro, et al.
Publicado: (2019)

BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
por: Angelidou, Asimenia, et al.
Publicado: (2020)

Lessons from the failure of the adenovector HIV vaccine
por: Blais, Marie-Eve, et al.
Publicado: (2009)

Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice
por: Ghasemi, Amir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e97q7ffugvij6qeaboe2bhj107